Clotblog with Dr Samuel GoldhaberView all posts »
Statins for women: JUPITER hits another home runJun 1, 2010 14:45 EDT
Largely overlooked by primary-prevention trials, women account for one-third of the 18 000-patient population of the JUPITER trial. The results of the trial are staggering: rosuvastatin significantly reduces the risk for women of cardiovascular disease, including the risk of deep vein thrombosis and pulmonary embolism.
- Mora S, Glynn RJ, Hsia J, et al. Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation. 2010 Mar 9;121(9):1069-77. Epub 2010 Feb 22. Abstract.
- Duvernoy CS, Blumenthal R. The numbers are in: statins for the primary prevention of cardiovascular disease in women. Circulation. 2010 Mar 9;121(9):1063-5. Epub 2010 Feb 22. Abstract.
- Elton, C. Women, Heart Disease: Do Statin Drugs like Crestor Work? Time magazine. Mar. 29, 2010.
- Time magazine questions statin risks and benefits in women, but experts say drugs safe and effective. [heartwire > MediaPulse]; Mar 29, 2010.